|
Martinez-Garcia, J; Boix, AP; Henarejos, PS; Lucas, MDJ; Saura, AS; Luengo, M; Vicente, RC; Ortiz, MJM; Balsalobre, J; Barrio, PDLMD; Garre, EG; Garcia, E; Marin, G; Torralba, EG; de la Pena, FA; Collado, D; Lopez, A; Quiros, T; Sanchez, DA; Romero, JLA. Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study. ANNALS OF ONCOLOGY. 2020; 31:S358-S358. 10.1016/j.annonc.2020.08.393
AÑO: 2020; IF: 32.976
|
|
Cascales Campos P, Martinez Insfran LA, Wallace D, Gil J, Gil E, Gonzalez Gil A, Martinez J, Alonso Romero JL, Gonzalez Sanchez R, Parrilla P. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy. Clin Transl Oncol. 2020 Jun;22(6):852-859. doi: 10.1007/s12094-019-02195-8. Epub 2019 Aug 7. PubMed PMID: 31392644.
AÑO: 2020; IF: 3.405
|
|
Guillamon CF, Martinez-Sanchez MV, Gimeno L, Campillo JA, Server-Pastor G, Martinez-Garcia J, Martinez-Escribano J, Torroba A, Ferri B, Abellan DJ, Legaz I, Lopez-Alvarez MR, Moya-Quiles MR, Muro M, Minguela A. Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance. Cancer Immunol Res. 2019 Aug;7(8):1307-1317. doi: 10.1158/2326-6066.CIR-18-0847. Epub 2019 Jun 25. PubMed PMID: 31239317.
AÑO: 2019; IF: 8.728
|
|
Lorusso D, Hilpert F, Gonzalez Martin A, Rau J, Ottevanger P, Greimel E, Luck HJ, Selle F, Colombo N, Kroep JR, Mirza MR, Berger R, Pardo B, Grischke EM, Berton-Rigaud D, Martinez-Garcia J, Vergote I, Redondo A, Cardona A, Bastiere-Truchot L, du Bois A, Kurzeder C; PENELOPE trial investigators. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. Int J Gynecol Cancer. 2019 Sep;29(7):1141-1147. doi: 10.1136/ijgc-2019-000370. Epub 2019 Aug 15. PubMed PMID: 31420414.
AÑO: 2019; IF: 2.095
|
|
Guillamón CF, Martínez-Sánchez MV, Gimeno L, Mrowiec A, Martínez-García J, Server-Pastor G, Martínez-Escribano J, Torroba A, Ferri B, Abellán D, Campillo JA, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A. NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome. Cancer Immunol Res. 2018 Dec;6(12):1537-1547. doi: 10.1158/2326-6066.CIR-18-0022. Epub 2018 Sep 21. PubMed PMID: 30242020.
AÑO: 2018; IF: 8.619
|